IMMULAB
LIVE

Serial Number

79336602

Owner

IMMULAB PTY LTD

Attorney

Rebecca Liebowitz

Filing Date

Oct 4, 2021

Add to watchlist:

No watchlists yet
View on USPTO

IMMULAB Trademark

Serial Number: 79336602 • Registration: 6945376

IMMULAB is a trademark filed by IMMULAB PTY LTD on October 4, 2021. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

IMMULAB PTY LTD (4 trademarks)

SCORESBY VICTORIA 3179 , AU

Entity Type: 82

Trademark Details

Filing Date

October 4, 2021

Registration Date

January 10, 2023

Published for Opposition

October 25, 2022

Goods & Services

Pharmaceutical preparations and substances, namely, blood grouping serums and blood typing serums, namely, medical reagents and assays for testing blood to determine blood type; blood components for medical purposes, namely, platelets, plasma and red blood cells; pharmaceutical test kits in this class, being for diagnostic medical purposes, namely, diagnostic test kits comprised of medical diagnostic reagents and assays for clinical laboratory use in use in blood grouping and antibody screening; blood products for medical purposes, namely, blood plasma, reagent blood cells; reagents for medical use, namely, reagents for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; clinical medical reagents for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes; pharmaceutical preparations, namely, reagent red blood cells used for quality control in immunohematology tests to detect antibodies or immunoglobulin subtypes; diagnostic reagents for medical or veterinary use; pharmaceutical preparations, namely, reagent red blood cells for medical use and medical testing used to detect antibodies or immunoglobulin subtypes; test kits comprised of medical diagnostic reagents and assays for testing of body fluids; chemical reagents for medical purposes; biological reagents for medical use

Chemical and biological reagents for non-medical purposes; chemical test kits comprised of chemical preparations for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for scientific and/or industrial purposes; diagnostic and chemical reagents for testing for scientific and research purposes; chemical and biological reagents for non-medical purposes; chemical and biological reagents for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes, all the aforesaid being for scientific and research purposes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for anti-body screening, blood grouping, and the typing and detection of specific blood cells for scientific and research purposes

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Aug 15, 2025 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
May 17, 2023 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 26, 2023 FICS
FINAL DISPOSITION PROCESSED
Apr 26, 2023 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 10, 2023 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 10, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 10, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 25, 2022 NPUB
PUBLISHED FOR OPPOSITION
Oct 25, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 5, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 19, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 26, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2022 TROA
REFUSAL PROCESSED BY IB
Aug 23, 2022 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 29, 2022 RFCS
REFUSAL PROCESSED BY MPU
Jul 29, 2022 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 8, 2022 RFCR
NON-FINAL ACTION WRITTEN
Jul 7, 2022 CNRT
ASSIGNED TO EXAMINER
Jul 7, 2022 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 29, 2022 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 25, 2022 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 24, 2022 REPR